#AVXL↓

AVXL/ 12/12/2025 · 4:25 PM

Anavex Faces Setback in EU Alzheimer's Drug Review

Anavex Life Sciences receives negative EU opinion for blarcamesine Alzheimer's treatment but plans to request re-examination with new reviewers.

AVXL/ 11/14/2025 · 8:44 AM

Anavex Faces Setback in European Alzheimer's Drug Approval

Anavex Life Sciences receives negative trend vote from EMA for blarcamesine Alzheimer's treatment but plans re-examination and continues FDA discussions.